These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 9821074

  • 21. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
    Lu S, Tiekso J, Hietanen S, Syrjänen K, Havu VK, Syrjänen S.
    Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
    [Abstract] [Full Text] [Related]

  • 22. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM, Ramaekers FC, Broers JL, Hutchison CJ, Neumann HA.
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [Abstract] [Full Text] [Related]

  • 23. Progressive alterations of cytokeratin expressions in the process of chronic arsenism.
    Yu HS, Chiou KS, Chen GS, Yang RC, Chang SF.
    J Dermatol; 1993 Dec; 20(12):741-5. PubMed ID: 7509818
    [Abstract] [Full Text] [Related]

  • 24. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA, Sangueza OP.
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [Abstract] [Full Text] [Related]

  • 25. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease.
    Yeh S, How SW, Lin CS.
    Cancer; 1968 Feb; 21(2):312-39. PubMed ID: 4952508
    [No Abstract] [Full Text] [Related]

  • 26. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
    Matsumoto M, Furihata M, Kurabayashi A, Ohtsuki Y.
    Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
    [Abstract] [Full Text] [Related]

  • 27. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH, Robinson RA.
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [Abstract] [Full Text] [Related]

  • 28. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers.
    Lee CH, Wu SB, Hong CH, Liao WT, Wu CY, Chen GS, Wei YH, Yu HS.
    Am J Pathol; 2011 May; 178(5):2066-76. PubMed ID: 21514422
    [Abstract] [Full Text] [Related]

  • 29. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M, Kay E.
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
    Vidal D, Matías-Guiu X, Alomar A.
    Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
    Smith KJ, Williams J, Corbett D, Skelton H.
    Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
    [Abstract] [Full Text] [Related]

  • 34. Arsenic carcinogenesis in the skin.
    Yu HS, Liao WT, Chai CY.
    J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
    Chen SY, Takeuchi S, Moroi Y, Hayashida S, Kido M, Chen SJ, Tomoeda H, Uenotsuchi T, Tu YT, Furue M, Urabe K.
    J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
    [No Abstract] [Full Text] [Related]

  • 36. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T, Zamolo G, Coklo M, Hadzisejdic I, Stemberger C, Zauhar G.
    Pathol Res Pract; 2006 Sep; 202(8):599-607. PubMed ID: 16781827
    [Abstract] [Full Text] [Related]

  • 37. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
    Mateoiu C, Pirici A, Bogdan F.
    Rom J Morphol Embryol; 2011 Sep; 52(1 Suppl):315-9. PubMed ID: 21424069
    [Abstract] [Full Text] [Related]

  • 38. Quantitative and morphological changes of Langerhans cells in Bowen's disease from patients with chronic arsenicism.
    Wang BJ, Lee YY, Mak CP, Kao HF, Hsu ML, Hsien JR.
    J Formos Med Assoc; 1991 Nov; 90(11):1093-8. PubMed ID: 1687057
    [Abstract] [Full Text] [Related]

  • 39. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR, Min SK, Min K, Jun SY, Seo J, Kim KH, Choi J.
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [Abstract] [Full Text] [Related]

  • 40. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.
    Batinac T, Zamolo G, Jonjić N, Gruber F, Petrovecki M.
    Tumori; 2004 Jan; 90(1):120-7. PubMed ID: 15143984
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.